Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)

D. Mischoulon; L. Hylek; A. S. Yeung; A. J. Clain; L. Baer; C. Cusin; D. F. Ionescu; J. E. Alpert; D. P. Soskin; M. Fava

doi:10.1016/j.jad.2017.10.040

Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)

D. Mischoulon, L. Hylek, A. S. Yeung, A. J. Clain, L. Baer, C. Cusin, D. F. Ionescu, J. E. Alpert, D. P. Soskin, M. Fava

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The authors regret that the order of the authors was incorrect. The correct order is the following: Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Fava M, Soskin DP. As mentioned in the original publication, Drs Soskin and Fava contributed equally to the inception, hypotheses, and design that formed the basis of the study and are considered as co-senior authors. The authors would like to apologise for any inconvenience caused.

Original language	English (US)
Pages (from-to)	198
Number of pages	1
Journal	Journal of Affective Disorders
Volume	227
DOIs	https://doi.org/10.1016/j.jad.2017.10.040
State	Published - Feb 2018
Externally published	Yes

ASJC Scopus subject areas

Clinical Psychology
Psychiatry and Mental health

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.jad.2017.10.040

Fingerprint

Dive into the research topics of 'Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)'. Together they form a unique fingerprint.

Cite this

Mischoulon, D., Hylek, L., Yeung, A. S., Clain, A. J., Baer, L., Cusin, C., Ionescu, D. F., Alpert, J. E., Soskin, D. P., & Fava, M. (2018). Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029). Journal of Affective Disorders, 227, 198. https://doi.org/10.1016/j.jad.2017.10.040

Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029). / Mischoulon, D.; Hylek, L.; Yeung, A. S. et al.
In: Journal of Affective Disorders, Vol. 227, 02.2018, p. 198.

Research output: Contribution to journal › Comment/debate › peer-review

Mischoulon, D, Hylek, L, Yeung, AS, Clain, AJ, Baer, L, Cusin, C, Ionescu, DF, Alpert, JE, Soskin, DP & Fava, M 2018, 'Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)', Journal of Affective Disorders, vol. 227, pp. 198. https://doi.org/10.1016/j.jad.2017.10.040

Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C et al. Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029). Journal of Affective Disorders. 2018 Feb;227:198. doi: 10.1016/j.jad.2017.10.040

Mischoulon, D. ; Hylek, L. ; Yeung, A. S. et al. / Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi : 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029). In: Journal of Affective Disorders. 2018 ; Vol. 227. pp. 198.

@article{090ba6f71787480b824a9f991705a789,

title = "Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi: 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)",

abstract = "The authors regret that the order of the authors was incorrect. The correct order is the following: Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Fava M, Soskin DP. As mentioned in the original publication, Drs Soskin and Fava contributed equally to the inception, hypotheses, and design that formed the basis of the study and are considered as co-senior authors. The authors would like to apologise for any inconvenience caused.",

author = "D. Mischoulon and L. Hylek and Yeung, {A. S.} and Clain, {A. J.} and L. Baer and C. Cusin and Ionescu, {D. F.} and Alpert, {J. E.} and Soskin, {D. P.} and M. Fava",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2018",

month = feb,

doi = "10.1016/j.jad.2017.10.040",

language = "English (US)",

volume = "227",

pages = "198",

journal = "Journal of Affective Disorders",

issn = "0165-0327",

publisher = "Elsevier",

}

TY - JOUR

T1 - Corrigendum to “Randomized, proof-of-concept trial of low dose naltrexone for patients with breakthrough symptoms of major depressive disorder on antidepressants” [J. Affect. Disord. 208 (2017, Jan. 15) 6-14, doi

T2 - 10.1016/j.jad.2016.08.029, Epub 2016 Oct. 1](S0165032716304499)(10.1016/j.jad.2016.08.029)

AU - Mischoulon, D.

AU - Hylek, L.

AU - Yeung, A. S.

AU - Clain, A. J.

AU - Baer, L.

AU - Cusin, C.

AU - Ionescu, D. F.

AU - Alpert, J. E.

AU - Soskin, D. P.

AU - Fava, M.

PY - 2018/2

Y1 - 2018/2

N2 - The authors regret that the order of the authors was incorrect. The correct order is the following: Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Fava M, Soskin DP. As mentioned in the original publication, Drs Soskin and Fava contributed equally to the inception, hypotheses, and design that formed the basis of the study and are considered as co-senior authors. The authors would like to apologise for any inconvenience caused.

AB - The authors regret that the order of the authors was incorrect. The correct order is the following: Mischoulon D, Hylek L, Yeung AS, Clain AJ, Baer L, Cusin C, Ionescu DF, Alpert JE, Fava M, Soskin DP. As mentioned in the original publication, Drs Soskin and Fava contributed equally to the inception, hypotheses, and design that formed the basis of the study and are considered as co-senior authors. The authors would like to apologise for any inconvenience caused.

UR - http://www.scopus.com/inward/record.url?scp=85032370995&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032370995&partnerID=8YFLogxK

U2 - 10.1016/j.jad.2017.10.040

DO - 10.1016/j.jad.2017.10.040

M3 - Comment/debate

C2 - 29100152

AN - SCOPUS:85032370995

SN - 0165-0327

VL - 227

SP - 198

JO - Journal of Affective Disorders

JF - Journal of Affective Disorders

ER -